Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOTEGRAVIR Cause Intentional dose omission? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Intentional dose omission have been filed in association with CABOTEGRAVIR (Apretude). This represents 0.1% of all adverse event reports for CABOTEGRAVIR.

7
Reports of Intentional dose omission with CABOTEGRAVIR
0.1%
of all CABOTEGRAVIR reports
0
Deaths
0
Hospitalizations

How Dangerous Is Intentional dose omission From CABOTEGRAVIR?

Of the 7 reports.

Is Intentional dose omission Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does CABOTEGRAVIR Cause?

Product dose omission issue (1,121) Off label use (1,049) Injection site pain (924) Viral load increased (452) Pain (399) Virologic failure (275) Pathogen resistance (270) Pyrexia (255) Product use in unapproved therapeutic environment (234) Inappropriate schedule of product administration (228)

What Other Drugs Cause Intentional dose omission?

DUPILUMAB (2,269) CERTOLIZUMAB PEGOL (1,253) ADALIMUMAB (845) TOFACITINIB (845) INFLIXIMAB (815) ABALOPARATIDE (623) ETANERCEPT (615) AMBRISENTAN (595) SODIUM OXYBATE (580) CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (518)

Which CABOTEGRAVIR Alternatives Have Lower Intentional dose omission Risk?

CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE CABOTEGRAVIR vs CABOZANTINIB CABOTEGRAVIR vs CABOZANTINIB S-MALATE CABOTEGRAVIR vs CAFFEINE CABOTEGRAVIR vs CALASPARGASE PEGOL

Related Pages

CABOTEGRAVIR Full Profile All Intentional dose omission Reports All Drugs Causing Intentional dose omission CABOTEGRAVIR Demographics